Something profound is happening in Canada’s food economy, and most people haven’t quite grasped it yet. It’s not a new grocer, a new restaurant chain, or even a new diet trend. It’s a class of medications — GLP-1 drugs such as Ozempic and Wegovy — that are rapidly altering how Canadians eat, drink, and shop.

For years, industry leaders have assumed that food demand is stable, predictable, and tied mostly to income and demographics. But for the first time in modern history, chemistry is reshaping consumption faster than economics.

According to a new national survey conducted by the Dalhousie University Agri-Food Analytics Lab, in partnership with Caddle, approximately two million Canadians are using a GLP-1 drug strictly for weight loss. To put that in perspective, that is roughly the com

See Full Page